Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
Medicus Pharma Ltd. (Nasdaq: MDCX, TSXV: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets.
Investor's Business Daily on MSN46m
Hyatt Announces $2.6 Billion Resort Acquisition; Marriott Earnings Due
Marriott, Wyndham Hotels and Hyatt roll out Q4 results for hotel companies this week, with their stocks near buy points. Analysts will be closely watching room night forecasts, as well as revenue per ...